Shaily Engineering Plastics Limited — Investor Meet, 27-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Shaily Engineering Plastics posted strong Q4 & FY26. FY26 Revenue jumped 26% to INR991 Cr, PAT surged 83% to INR170 Cr, expanding margins. 🚀 Healthcare revenue doubled in Q4 (+139% FY26) driven by successful Semaglutide pen launches in Canada & India, with US tentative approval. More capacity is ramping up.

New growth vectors include consumer electronics (supplies started) & semiconductor trays (deal signed, supplies Q4 FY27). Industrial segment grew well. Consumer (home furnishings) saw headwinds but expects rebound. Fundraise enabling resolution (up to INR500 Cr) provides flexibility. Management expresses confidence in sustainable growth and improving margins.